OasisLMS

U.S. drug-related overdose deaths continue rising, with more than 100,000 individuals dying in the 12-month period ending in April 2021. Amidst this, hospitalists must be first-line responders in being able to assess and diagnose opioid use disorder, while offering evidence-based treatment. Participants will leave this session empowered to provide life-saving treatment for hospitalized patients with opioid use disorder.

This session is moderated by Joseph Sweigart, MD, FHM, SFHM. Our panelists include Marlene Martin, MD and Susan Calcaterra, MD, MPH.

This session will provide a simplified approach to the evaluation of syncope. We will review high-yield tests and features to aid in appropriate evaluation and disposition of patients with syncope.

This session is presented by Lauren Westafer, DO, MPH, MS, FACEP and Carrie Herzke, MD, SFHM, FAAP, FACP. Our moderator is Lily Ackermann, MD, ScM, FHM.

With all the complicated patients you take care of on a daily basis, don't you long for the straightforward GI bleeder? We will discuss GI Bleeds from both the hospitalist perspective with medical management, but also from the GI perspective highlighting what is done in the endoscopy suite.

This session is presented by Marijeta Pekez, MD and Benjamin Verplanke, MD, FACP, FHM. Our moderator is Jagriti Chadha, MD, FHM, SFHM.

This session will review appropriate clinical indications for cardiac biomarker testing, strategies to avoid unnecessary biomarkers testing and effective quality improvement interventions to reduce unnecessary biomarker testing among hospitalized patients.

This session is presented by Christine Soong, MD, MSc and David Berg, MD, MPH. Our moderators are Lily Ackermann, MD, ScM, FHM and Ebrahim Barkoudah, MD, FACP, MPH, SFHM.

This session will focus on the current evidence for implementation strategies to promote the adoption of guideline directed medical therapy in heart failure. We will cover the gaps in care, the rationale for implementation science in this condition, recent implementation trial evidence, and a look toward the future for implementation science across cardiometabolic care.

This session is presented by Safia Chatur, MD and Ankeet Bhatt, MD, MBA, ScM. Our moderators are Lily Ackermann, MD, ScM, FHM and Ebrahim Barkoudah, MD, FACP, MPH, SFHM.

This session will explore substance use disorders beyond OUD. We will discuss treatment of alcohol use disorder (AUD) beyond just simply treating alcohol withdrawal, including initiating medications to treat AUD (MAUD) prior to discharge and implementing evolving alcohol withdrawal management into clinical practice. In addition, given the rapidly changing unregulated supply, we will highlight critical pearls hospitalists must know about adulterants in the unregulated drug supply.

This session is presented by Raagini Jawa, MD, MPH, FASAM and Melissa Bregger, MD, FACP. Our moderator is Jagriti Chadha, MD, FHM, SFHM.